We offer experienced staff:

CRO   Clinical Research Associate (CRA)
CRO   Senior Clinical Research Associate (S-CRA)
CRO   Regulatory Affair Manager
CRO   Freelance CRA

Our previous experience (indication & amount of sites):

Community-acquired Pneumonia (phase III) 15 sites in Poland (multinational trial with 130 sites)

Arterial Hypertension (phase IV) 26 sites in Poland (multinational trial with 60 sites)

Epilepsy (phase II) 7 sites in Poland (multinational trial with 20 sites)

Osteoarthritis (phase lIa) 6 sites in Poland (multinational trial with 18 sites)

Psoriasis (phase lIa) 6 sites in Poland (multinational trial with 20 sites) (projected has been stopped)

Osteoarthritis (phase III) 6 sites in Poland (multinational trial with 12 sites)

Diabetic Retinopathy (phase III) 6 sites in Poland (multinational trial with 24 sites)

Epilepsy (phase III) 8 sites in Poland (multinational trial with 50 sites)

Hormone Replacement Therapy (phase III) 4 sites in Poland (multinational trial with 18 sites)

Osteoarthritis (phase Ilb) 6 sites in Poland (multinational trial with 42 sites)

Crohn's Disease 3 + 2 sites in Poland (international study)

Bronchial Asthma ( phase III) 8 sites in Poland (international study)

COPD (phase III) 9 sites in Poland (international study)

Gastric Ulcer (phase III) 7 sites in Poland (international study)

Duodenal Ulcer (phase III) 6 sites in Poland, (international study)

Reflux Disease (phase III) 8 sites in Poland, (international study)

Gastric Bleeding (phase III) 2 sites in Poland, (international study)

COPD (phase II) 3 sites in Poland, (international study)

Multiplex Sclerosis (phase II) 8 sites in Poland (international study)

VACCINATION STUDIES Management, co-monitoring